[The program of lowering of residual vascular risk (The Residual Vascular Risk Reduction Initiative). Part II. Methods of correction].
M Iu
MIu
Zubareva
A V
AV
Susekov
D050197:Atherosclerosis / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D002318:Cardiovascular Diseases / Q000150:complications / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D002986:Clinical Trials as Topic; D050171:Dyslipidemias / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D015438:Health Behavior; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D000960:Hypolipidemic Agents / Q000145:classification / Q000494:pharmacology*; D008019:Life Style; D010353:Patient Education as Topic; D016730:Program Development; D012307:Risk Factors; D055502:Secondary Prevention / Q000193:education / Q000379:methods*
D000960:Hypolipidemic Agents